We are proud to report that Cromos Pharma has successfully completed a company-wide inspection by RosZdravNadzor, the Russian State regulatory agency, which was held on January 14-17, 2014.
In the course of this 4-day inspection an in-depth review of Cromos Pharma's SOPs, compliance with the Russian and international regulations, contracts with the sponsors, communications with the sites, etc, have not revealed any significant deviations or findings.
The results of this inspection attest to the highest standards and excellence of Cromos Pharma's operational structure and the hard work and determination of its team.
About Cromos Pharma, LLC
Cromos Pharma, LLC is a premier contract research organization (CRO) with operations in Ukraine, Russia, Belarus, Georgia, the Baltic States and Eastern Europe and a business development office in the United States. The company provides a full spectrum of trial-related services, which include regulatory approvals, medical writing, feasibility assessments, monitoring, project management and warehousing. Cromos Pharma, LLC is a privately owned company.
Tuesday 1 December marked World AIDS Day 2020. Although throughout this year our focus has been on the coronavirus pandemic, World AIDS Day is an opportunity to reflect on another pandemic where a virus passed from animals to humans with devastating consequences. To date 77 million people worldwide have been infected with HIV. In spite of innovative new treatments 35 million people have died from the virus.
If you missed the live webinar “Where in the world should I locate my pivotal clinical trial?” you can now watch the recording by clicking here. The webinar hosted by the Society of Physician Entrepreneurs (SoPE) and Workforce Genetics features Cromos Pharma's CEO Vlad Bogin, M.D, FACP.